[ Price : $8.95]
FDA grants accelerated approval to Mirati Therapeutics for its Krazati (adagrasib) NDA, indicated for treating adult patients with...[ Price : $8.95]
Icelands Alvotech says it expects an FDA decision on its BLA for a Humira biosimilar on 4/13.[ Price : $8.95]
Celltrion USA submits a BLA to FDA for a novel subcutaneous formulation of its infliximab to be used as maintenance therapy in som...[ Price : $8.95]
FDA warns Pompano Beach, FL-based Empowered Diagnostics about illegally manufacturing and distributing Covid-19 tests.[ Price : $8.95]
FDA accepts for review a Pfizer NDA for etrasimod to treat some patients with ulcerative colitis.[ Price : $8.95]
FDA warns Camarillo, CA-based Green Pharmaceuticals that it is distributing an adulterated unapproved new drug.[ Price : $8.95]
Madrigal Pharmaceuticals says its resmetirom met FDA-suggested endpoints in the pivotal Phase 3 MAESTRO-NASH trial to treat nonalc...[ Price : $8.95]
Rep. Abigail Spanberger asks FDA and the DEA how they will work together and independently to overcome the current shortage of Add...